Beijing Chunlizhengda Medical Instruments (HKG:1858, SHA:688236) recorded a 55% decline in attributable profit for the year 2024 to 125 million yuan from 277.8 million yuan in the year-ago period, a Thursday filing with the Hong Kong bourse stated.
Basic EPS was 0.33 yuan in the fiscal year, down from 0.72 yuan in the previous corresponding year.
The orthopedic medical device company's total operating revenue also fell by 33% to 805.9 million yuan in the fiscal year from 1.21 billion yuan a year prior.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。